Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hjelte

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 11, 2011
Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trialsD Bilton, G Canny, S Conway, et al.
Pediatric Pulmonology|May 10, 2002
Predictors of deterioration of lung function in cystic fibrosisC Schaedel, I de Monestrol, L Hjelte, et al.
Diabetologia|September 9, 2011
Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional StudyT Pincikova, K Nilsson, I E Moen, et al.
European Journal of Clinical Nutrition|September 23, 2010
Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional StudyT Pincikova, K Nilsson, I E Moen, et al.
Thorax|March 26, 2009
Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosisC Goubau, M Wilschanski, V Skalická, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 11, 2011
Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trialsD Bilton, G Canny, S Conway, et al.
Pediatric Pulmonology|May 10, 2002
Predictors of deterioration of lung function in cystic fibrosisC Schaedel, I de Monestrol, L Hjelte, et al.
Diabetologia|September 9, 2011
Vitamin D deficiency as a risk factor for cystic fibrosis-related diabetes in the Scandinavian Cystic Fibrosis Nutritional StudyT Pincikova, K Nilsson, I E Moen, et al.
European Journal of Clinical Nutrition|September 23, 2010
Inverse relation between vitamin D and serum total immunoglobulin G in the Scandinavian Cystic Fibrosis Nutritional StudyT Pincikova, K Nilsson, I E Moen, et al.
Thorax|March 26, 2009
Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosisC Goubau, M Wilschanski, V Skalická, et al.
Pageof 5